{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:12:01Z","timestamp":1781485921029,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"COST Action","award":["TD1004"],"award-info":[{"award-number":["TD1004"]}]},{"name":"Program for the Promotion of the Exchange and Scientific Cooperation between Greece and Germany IKYDA"},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["DFO Ro 985\/40-1"],"award-info":[{"award-number":["DFO Ro 985\/40-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Russian Foundation for Fundamental Research","award":["RFBR 15-53-12372"],"award-info":[{"award-number":["RFBR 15-53-12372"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.nucmedbio.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,14]],"date-time":"2016-02-14T09:30:25Z","timestamp":1455442225000},"page":"280-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study"],"prefix":"10.1016","volume":"43","author":[{"given":"Valery","family":"Radchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Bouziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Tsotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Paravatou-Petsotas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana de","family":"la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Loudos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Filosofov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eisenhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ponsard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Roesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.nucmedbio.2016.02.003_bb0005","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1039\/c0dt01504k","article-title":"Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS","volume":"40","author":"R\u00f6sch","year":"2011","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0015","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2967\/jnumed.107.041301","article-title":"In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft","volume":"48","author":"Nagengast","year":"2007","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2016.02.003_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1349-7006.2010.01763.x","article-title":"Positron emission tomography and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts","volume":"201","author":"Paudyal","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0025","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2967\/jnumed.109.071043","article-title":"89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922","volume":"51","author":"Nagengast","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0030","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ijc.25409","article-title":"PET imaging of tumor angiogenesis in mice with VEGF-A-targeted 86Y-chx-a\u2033-dtpa-bevacizumab","volume":"128","author":"Nayak","year":"2011","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.nucmedbio.2016.02.003_bb0035","first-page":"e58949","article-title":"Detection of rapalog-mediated therapeutic response in renal cancer xenografts using \u2076\u2074Cu-bevacizumab immunoPET","volume":"8","author":"Chang","year":"2013"},{"issue":"4","key":"10.1016\/j.nucmedbio.2016.02.003_bb0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/1568026611313040005","article-title":"89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals","volume":"13","author":"Vugts","year":"2013","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"10.1016\/j.nucmedbio.2016.02.003_bb0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/157340611796799186","article-title":"89Zr radiochemistry for positron emission tomography","volume":"7","author":"Severin","year":"2011","journal-title":"Med Chem"},{"issue":"4","key":"10.1016\/j.nucmedbio.2016.02.003_bb0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/cbr.2009.0674","article-title":"Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research","volume":"24","author":"Anderson","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0055","first-page":"510","article-title":"Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-DPHE1-TYR3-octreotide ([86Y]smt487) using positron emission tomography in non-human primates and calculation of","volume":"30","author":"Rosch","year":"2003","journal-title":"Med Mol Imag"},{"issue":"5","key":"10.1016\/j.nucmedbio.2016.02.003_bb0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2174\/157340611796799249","article-title":"86Y based PET radiopharmaceuticals: radiochemistry and biological applications","volume":"7","author":"Nayak","year":"2011","journal-title":"Med Chem"},{"issue":"2","key":"10.1016\/j.nucmedbio.2016.02.003_bb0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1874471011104020076","article-title":"Radiobromine-labelled tracers for positron emission tomography: possibilities and pitfalls","volume":"4","author":"Tolmachev","year":"2011","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1524\/ract.2002.90.7_2002.411","article-title":"Radiochemical separation of no-carrier-added radioniobium from zirconium targets for application of 90Nb-labelled compounds","volume":"90","author":"Busse","year":"2002","journal-title":"Radiochim Acta"},{"issue":"5","key":"10.1016\/j.nucmedbio.2016.02.003_bb0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1515\/ract-2013-2156","article-title":"Separation of 90Nb from zirconium target for application in immuno-PET","volume":"102","author":"Radchenko","year":"2014","journal-title":"Radiochim Acta"},{"issue":"11","key":"10.1016\/j.nucmedbio.2016.02.003_bb0080","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1524\/ract.2012.1971","article-title":"90Nb \u2014 a potential PET nuclide: production and labeling of monoclonal antibodies","volume":"100","author":"Radchenko","year":"2012","journal-title":"Radiochim Acta"},{"issue":"9","key":"10.1016\/j.nucmedbio.2016.02.003_bb0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.nucmedbio.2014.06.006","article-title":"Desferrioxamine as an appropriate chelator for 90Nb: comparison of its complexation properties for M-Df-octreotide (M=Nb, Fe, Ga, Zr)","volume":"41","author":"Radchenko","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00259-009-1263-1","article-title":"p-sothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging","volume":"37","author":"Perk","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2016.02.003_bb0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/179673a0","article-title":"Turn-over of carrier-free zirconium in man","volume":"179","author":"Mealy","year":"1957","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.nucmedbio.2016.02.003_bb0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/02841856709138571","article-title":"Distribution of zirconium and niobium in mice: autoradiographic study","volume":"6","author":"Backstrom","year":"1967","journal-title":"Acta Radiol Diagn"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115300627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805115300627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T11:57:45Z","timestamp":1537012665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805115300627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0969805115300627"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.02.003","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}